AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06139575 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lutetium Lu 177 JH020002 Injection
Description: Patients will receive Lutetium Lu 177 JH020002 Injection every 6 weeks for a maximum of 6 doses. Doses range between 1.85 and 8.88 GBq (50-240 mCi)
Study NCT05739422 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Neuropilates online exercise class
Description: Online, remotely supervised neuropilates exercise class
Study NCT05739422 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Online generalised exercise class
Description: Online, remotely supervised generalised exercise class
Study NCT05739422 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Unsupervised home exercise programme
Description: Unsupervised, home based generalised exercise programme
Study NCT05451134 — intervention group
Intervention type: OTHER
Intervention: Catecholamines
Description: Focus on whether catecholamine exposure is associated with dysglycemia in patients with pheochromocytoma and paraganglioma
Study NCT04135677 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Description: Drug: Rivaroxaban 20mg Duration of treatment: 12 weeks(12 weeks for DAPT afterwards)
Study NCT04135677 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: DAPT
Description: Drug: Aspirin 100mg and clopidogrel 75mg Duration of treatment:24 weeks
Study NCT05300815 — intervention group
Intervention type: OTHER
Intervention: Delphi Questionaire
Description: This study involves the use of questionnaires across 3 rounds as follows:~The objectives of round 1 are to collect participant demographic information and generate a list of adverse events. Round 1 will be open for 3 weeks with email reminders being provided at weeks 1 and 2.~The objectives of round 2 will be to share a list of adverse events generated from round 1 (with the addition of adverse events identified in literature if not generated in round 1) and allow participants to rate from 1-4 how important each item is for inclusion on informed consent. As per round 1, the round 2 questionnaire will remain active for 3 weeks with email reminders sent at weeks 1 and 2.~The objective of round 3 is to further gain consensus on adverse events from the results of round 2 where agreement was not reached. Round 3 remains active for 3 weeks with email reminders sent at weeks 1 and 2.
Study NCT05750381 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Micrococcus luteus Blis Q24 balm
Description: Balm formulation containing probiotic bacteria Micrococcus luteus Q24 for topical applications.
Study NCT06055205 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: PAC-plan
Description: The participants will be asked to complete electronic questionnaires at baseline, and at 6 weeks and 52 weeks after discharge from the hospital. The completion of these questionnaires will take place during the 6-week follow-up appointment at the hospital (a standard follow-up for all patients undergoing surgery at the Division of Orthopedic Surgery, Oslo University Hospital, Norway). Additionally, participants will be invited for a phone-based follow-up appointment with the study coordinator 52 weeks after discharge. The participants will receive the questionnaires electronically via SMS or email. If electronic options are not feasible, data can be collected through paper questionnaires sent by mail. Data will not be directly obtained from general practitioners.
Study NCT05797181 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: medical nutrition therapy in kidney diseases
Description: Planning and implementation of diets containing high protein, low potassium, low phosphorus, personalized adjusted carbohydrates
Study NCT05949346 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Multiple Family Narrative Therapy (MFNT)
Description: MFNT consist of 4 weekly group sessions with selected themes from both multiple family therapy (MFT) and narrative therapy (NT) offered in a group format. The family is treated as a system through both psychodynamic practices and attachment theories to manage symptoms, to achieve family resilience, and to empower both parents and child to share their unique and lived value-driven experiences. MFNT provides families with therapeutic environments that are conducive to learning and modelling in order to facilitate the process of building healthier parent-child dyads.
Study NCT05949346 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: School services for families of children with Dyslexia
Description: Selected school personnel will deliver services as usual for the control group.
Study NCT04620746 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Penicillin Major Determinant (PrePen) Skin Testing
Description: Skin testing followed by oral challenge with amoxicillin 250 mg single dose
Study NCT04620746 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Direct Oral challenge
Description: Direct oral challenge with test dose of amoxicillin 25mg followed by amoxicillin 250mg single dose
Study NCT05237167 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Shoulder reduction
Description: This is standard of care and only measure as a time component outcome in the study
Study NCT05237167 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Shoulder reduction
Description: This is standard of care and only measure as a time component outcome in the study
Study NCT05059873 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prednisone
Description: Oral prednisone 40mg/day for five consecutive days
Study NCT05750381 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo balm
Description: Placebo balm formulation for topical applications.
Study NCT05031624 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CDX-0159
Description: Single subcutaneous dose of one of four dosages of CDX-0159
Study NCT05031624 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Normal saline
Description: Single subcutaneous dose of normal saline
Study NCT05600608 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Oral Stimulant Drink
Description: please see description of the drink in the arm/ group section
Study NCT05600608 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Oral Stimulant Drink
Description: please see description of the drink in the arm/ group section
Study NCT05631067 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Remote blood pressure monitoring
Description: Participants will receive a blood pressure monitor to check daily BPs for two weeks post partum
Study NCT05631067 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: NT proBNP assessment
Description: Participants will have biomarker assessment at 0-2 days postpartum
Study NCT05631067 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: NT proBNP assessment
Description: Participants will have biomarker assessment at 0-2 days postpartum
Study NCT05059873 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Oral placebo of 40mg/day for five consecutive days
Study NCT04740801 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Ablation procedure
Description: Catheter ablation of pulmonary veins with the Rhythmia HDx mapping system, IntellaMap Orion mapping catheter and IntellaNav StablePoint ablation catheter
Study NCT05064397 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Eptinezumab
Description: Eptinezumab will be administered per schedule specified in the arm description.
Study NCT04526288 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Allogeneic Hematopoietic Stem Cell Transplantation
Description: Undergo alloHCT
Study NCT04526288 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Allogeneic Hematopoietic Stem Cell Transplantation
Description: Undergo alloHCT
Study NCT04526288 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Liposome-encapsulated Daunorubicin-Cytarabine
Description: Given IV
Study NCT04801030 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: YourCoViDVaxFacts
Description: The intervention will be delivered via multiple strategies- social media (YouTube, Facebook), radio, newspaper, tv ads, community partner networks. Participants receive culturally-tailored message on COVID-19 and the vaccine. The strategies will have a link that will open to a website that is optimized for viewing on a computer or mobile phone which has the look and feel of an app, but without requiring the user to download anything to the phone. On the website, participants will be prompted to select their top concerns from a list. Based on the responses, the top barriers or need will each be mapped to a corresponding educational message, which will be displayed to the user with appropriate images or graphics.
Study NCT04820725 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Plantar pressure and gait
Description: Gait analyses (cadence, stride length, swing phase duration, step duration and double stand duration) will be evaluated using Win-Track platform (MEDICAPTEURS Technology, France).
Study NCT05982743 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Lactobacillus casei strain Shirota fermented milk
Description: Participants will take one bottle (65 ml) of Yakult® drink daily, containing at least 6.5 x 10\^9 CFU of Lactobacillus casei strain Shirota, for a period of 4 weeks. Subsequently, there will be a two-week follow-up period.
Study NCT05021393 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Clinical Pharmacist Intervention
Description: Medication review, patient education, counseling, and corresponding written recommendation will be performed by clinical pharmacists for all randomized patients.
Study NCT05673980 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vitamin D2
Description: Participants in the vitamin D2 group received 200,000 IU of vitamin D2 orally on the first day of the trial and again two weeks later
Study NCT05673980 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: This group will not do any intervention
Study NCT05708248 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: pentoxifylline
Description: 400 mg pentoxifylline tablets twice daily with meals for 6 months
Study NCT05989061 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PEEK customized healing abutment
Description: Guided delayed implant and a customized PEEK healing abutment placed simultaneously with implant surgery
Study NCT05989061 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Titanium customized healing abutment
Description: Guided delayed implant and a customized Titanium healing abutment placed simultaneously with implant surgery
Study NCT05863663 — intervention group
Intervention type: OTHER
Intervention: questionnaire
Description: cross sectional questionnaire
Study NCT04323163 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physical Activity
Description: 3 sessions per week, 60 minutes per session for 6 months
Study NCT04323163 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Physical Activity
Description: 3 sessions per week, 60 minutes per session for 6 months
Study NCT05219760 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: LIVIA
Description: The study aim to compare the efficacy of an IBI targeting complicated grief symptoms (LIVIA 2.0) compared to an already investigated IBI (LIVIA 1) using a guidance on demand design in a randomised controlled trial.~Both programs are composed of 10 weekly sessions proposing educational material, questionnaires and exercises. They are based on current scientific theories of grief but present their content differently. Compared to LIVIA 1, LIVIA 2.0 is less based on academic readings and participants can choose more freely which topics and exercises they want to do. LIVIA 2.0 also offers a system of reminder messages to maximize adherence as well as more elaborate automated guidance.
Study NCT05219760 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: LIVIA
Description: The study aim to compare the efficacy of an IBI targeting complicated grief symptoms (LIVIA 2.0) compared to an already investigated IBI (LIVIA 1) using a guidance on demand design in a randomised controlled trial.~Both programs are composed of 10 weekly sessions proposing educational material, questionnaires and exercises. They are based on current scientific theories of grief but present their content differently. Compared to LIVIA 1, LIVIA 2.0 is less based on academic readings and participants can choose more freely which topics and exercises they want to do. LIVIA 2.0 also offers a system of reminder messages to maximize adherence as well as more elaborate automated guidance.
Study NCT05002231 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Losmapimod 15 mg oral tablet
Description: Subjects will receive one losmapimod 15 mg tablet by mouth under fasted conditions.
Study NCT05002231 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Losmapimod two 7.5 mg oral tablets
Description: Subjects will receive two losmapimod 7.5 mg tablets by mouth under fasted conditions.
Study NCT05002231 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Losmapimod one 15 mg oral tablet
Description: Subjects will receive one losmapimod 15 mg tablet by mouth under fed conditions.
Study NCT05234294 — intervention group
Intervention type: OTHER
Intervention: Survey
Description: We will investigate symptoms through monthly surveys.
Study NCT05296369 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Folic acid
Description: Folic acid was added during the period prior to concurrent chemoradiotherapy
Study NCT05210998 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Gradual Aerobic exercise training AND Respiratory muscle training
Description: Combined Exercise Group
Study NCT05210998 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Gradual Aerobic exercise training
Description: Aerobic exercise Group
Study NCT04668118 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Diquafosol
Description: As a P2Y2 receptor agonist, diquafosol can be used to stabilize the tear film by stimulating P2Y2 receptors on the corneal epithelial cells and conjunctival goblet cell, which increase the secretion of tear fluid and mucin on the ocular surface, thereby repairing the ocular surface and stabilizing the tear film.
Study NCT06540365 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Pathways and Resources for Engagement and Participation (PREP)
Description: Each participant will work individually with an occupational therapist (OT) to pursue one leisure-oriented, community-based activity chosen by the young person. The participant will choose the community program using the PREP 5 steps (Make goals; Map out a plan; Make it happen; Measure the process and outcomes; Move forward). The OT will then search for the appropriate program, identify and remove potential environmental barriers to participation in that activity (e.g., accessibility, equipment), and educate program instructors regarding the person's specific needs. This process will include an expected 8 sessions lasting 12 to 18 weeks (depending on the assigned baseline length).
Study NCT04926740 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Ringer's lactate
Description: Ringer's lactate is the most commonly used balanced crystalloid. Compared to normal saline, balanced crystalloids have chloride concentrations similar to human plasma; therefore, treatment with balanced crystalloids may lead to faster DKA resolution.
Study NCT04926740 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Ringer's lactate
Description: Ringer's lactate is the most commonly used balanced crystalloid. Compared to normal saline, balanced crystalloids have chloride concentrations similar to human plasma; therefore, treatment with balanced crystalloids may lead to faster DKA resolution.
Study NCT04973839 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Video optimizing expectations before PMR (unguided) + Progressive Muscle Relaxation (PMR)
Description: Participants watch a video aiming to optimize participants' expectations before undergoing a single PMR session without personal support of the experimenter (unguided). The PMR session involves learning to monitor tension in each specific muscle group in the body by deliberately inducing tension in each group. This tension is then released, with attention paid to the contrast between tension and relaxation.
Study NCT04973839 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Video optimizing expectations before PMR (guided) + Progressive Muscle Relaxation (PMR)
Description: Participants watch a video aiming to optimize participants' expectations before undergoing a single PMR session with the personal support of the experimenter (guided). The PMR session involves learning to monitor tension in each specific muscle group in the body by deliberately inducing tension in each group. This tension is then released, with attention paid to the contrast between tension and relaxation.
Study NCT04973839 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Neutral video before PMR (unguided) + Progressive Muscle Relaxation (PMR)
Description: Participants watch a neutral video (not aiming to optimize participants' expectations) before undergoing a single PMR session without personal support of the experimenter (unguided). The PMR session involves learning to monitor tension in each specific muscle group in the body by deliberately inducing tension in each group. This tension is then released, with attention paid to the contrast between tension and relaxation.
Study NCT04973839 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Neutral video before PMR (guided)+ Progressive Muscle Relaxation (PMR)
Description: Participants watch a neutral video (not aiming to optimize participants' expectations) before undergoing a single PMR session with the personal support of the experimenter (guided).The PMR session involves learning to monitor tension in each specific muscle group in the body by deliberately inducing tension in each group. This tension is then released, with attention paid to the contrast between tension and relaxation.
Study NCT05349032 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: OTHER
Intervention: Curcumin
Description: Oral supplement
Study NCT05602974 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: stereotactic body radiation therapy
Description: adjuvant stereotactic body radiation therapy
Study NCT05602974 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: regular follow-up
Description: regular follow-up
Study NCT05055778 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: SmokefreeTXT
Description: The program is identical to the publicly available program available through the National Cancer Institute Smokefree.gov Initiative but has been set up to be delivered through a research account. The program will send 3-5 messages a day over 7 weeks, with one week to prepare for a quit attempt and 6 weeks of cessation support messages. Participants can get real time support for cravings, mood, and slips by texting keywords to the program. They keywords are CRAVE, MOOD, and SLIP. Participants can also re-set their quit date by texting NEW. The program asks questions each week to ask about smoking status and about mood and cravings.
Study NCT05446480 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Desloratadine
Description: Oral ingestion 10mg pill 2 hours prior to heat strain trial. Second 10mg dose 24-hours later.
Study NCT05446480 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Oral ingestion 10mg inert pill 2 hours prior to heat strain trial. Second dose 24-hours later.
Study NCT05446480 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: No Intervention
Description: No pill ingestion during the trial - to discern the presence of a placebo effect from baseline inflammatory response
Study NCT04754321 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: External Beam Radiation Therapy
Description: Undergo EBRT
Study NCT04754321 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Intraoperative Radiation Therapy
Description: Undergo IORT
Study NCT04754321 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Given IV
Study NCT04754321 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Quality-of-Life Assessment
Description: Ancillary studies
Study NCT04754321 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Salvage Surgery
Description: Undergo salvage surgery
Study NCT06539988 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Clinician Coaching Sessions
Description: PCPs will receive interactive coaching sessions from a Clinician Coach 2 months into the intervention period and again at 4 months into the intervention period.
Study NCT06539988 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Personalized text messages to patients
Description: Drawing upon a library of messages that have previously been developed and refined, Veterans will receive 6 months of optimized text messages. The frequency of text messages will be determined based on feedback from Veterans in earlier phases of the research.
Study NCT05811260 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Myofascial Release technique
Description: on low back 3 repetitions (30 second rest between reps), lasting for 30 s for each myofascial track for 1 set to targeted muscles (plantar fascia, gastrocnemius, hamstrings, and erector spinae). The position will be held for 10-15 seconds when a pain point is found lacrosse ball excellent for this type of massage because their surface area is much less than that of foam rollers.